Swedbank
REGN icon

Swedbank’s Regeneron Pharmaceuticals REGN Stock Holding History

Swedbank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118M Sell
189,848
-25,742
-12% -$17.5M 0.1% 148
2026
Q1 		$167M Sell
215,590
-12,189
-5% -$9.33M 0.18% 108
2025
Q4 		$176M Buy
227,779
+20,409
+10% +$13.9M 0.17% 107
2025
Q3 		$117M Sell
207,370
-20,927
-9% -$11.8M 0.12% 139
2025
Q2 		$120M Buy
228,297
+4,509
+2% +$2.52M 0.13% 125
2025
Q1 		$142M Buy
223,788
+45,297
+25% +$31.2M 0.19% 104
2024
Q4 		$127M Buy
178,491
+29,128
+20% +$24.4M 0.16% 111
2024
Q3 		$157M Buy
149,363
+13,705
+10% +$15.3M 0.2% 102
2024
Q2 		$143M Buy
+135,658
New +$132M 0.19% 96
2024
Q1 		– Sell
-103,943
Closed -$91.3M – 687
2023
Q4 		$91.3M Buy
103,943
+57,238
+123% +$47.1M 0.15% 121
2023
Q3 		$38.4M Buy
46,705
+2,715
+6% +$2.13M 0.07% 201
2023
Q2 		$31.6M Buy
43,990
+1,227
+3% +$946K 0.05% 241
2023
Q1 		$35.1M Buy
42,763
+1,976
+5% +$1.49M 0.07% 217
2022
Q4 		$29.4M Buy
40,787
+2,555
+7% +$1.89M 0.06% 245
2022
Q3 		$26.3M Buy
38,232
+2,002
+6% +$1.26M 0.06% 249
2022
Q2 		$21.4M Buy
36,230
+1,281
+4% +$833K 0.05% 283
2022
Q1 		$24.4M Buy
34,949
+397
+1% +$251K 0.05% 295
2021
Q4 		$22.2M Sell
34,552
-6,030
-15% -$3.71M 0.04% 327
2021
Q3 		$24.6M Buy
40,582
+174
+0.4% +$108K 0.05% 302
2021
Q2 		$22.6M Hold
40,408
– – 0.04% 318
2021
Q1 		$19.1M Buy
+40,408
New +$19.7M 0.04% 342

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Swedbank's REGN Position: Q2 2026 in Review

Swedbank reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, selling an estimated $17.5M and leaving 189,848 shares worth $118M. The position accounts for 0.1% of the portfolio, ranked #148.

Swedbank first reported a position in REGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $176M in Q4 2025. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Swedbank held 189,848 shares of Regeneron Pharmaceuticals worth $118M as of Q2 2026.
  • Swedbank sold 25,742 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $17.5M.
  • Regeneron Pharmaceuticals made up 0.1% of Swedbank's portfolio in Q2 2026, its #148 holding.
  • Swedbank first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Swedbank's Regeneron Pharmaceuticals position peaked at $176M in Q4 2025.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.